fda shortage glp-1 Compounded GLP-1s: Why doctors worry and the is cracking down Microdose GLP-1 Amount: Compounding Regulations,

Through a novel process set up for this project, we generated postbiotics by letting the proprietary strain Lactobacillus paracasei LMG-S-26420 ferment for 72 h under anaerobic conditions in the presence of a freeze-dried botanical hydroalcoholic extract of garlic ( Allium sativum )

This reduces the risk of hypoglycaemia compared to some other diabetes medicines, though the risk increases when used alongside insulin or sulfonylureas

Side Effects: Sedation Parkinsonism symptoms QT prolongation (may be significant if taking with drugs inhibiting CYP3A4/5 or 2D6) Pharmacokinetics: undergoes rapid hepatic metabolism involving carbonyl reductase and CYP2D6 to 2 deuterated active metabolites -dihydrotetrabenazine (-HTBZ) and -dihydrotetrabenazine (-HTBZ), with eventual renal elimination of metabolites the -HTBZ and -HTBZ metabolites are primarily responsible for the pharmacological & therapeutic effects produced by the parent prodrug twice a day dosing effect half life 9.4 hours (Schneider et al, 2021) HT: Resistant Hypertension

$312.2M est

Key Takeaways Clinical trials show individuals using GLP-1 medications lose 2540% of their total weight loss as lean mass, though this appears largely adaptive to weight loss rather than a unique drug effect